SecteursCauris Management’s Fonds Cauris Croissance II invests in Cote...

Cauris Management’s Fonds Cauris Croissance II invests in Cote d’Ivoire-based pharmaceutical business, CIPHARM

-

Abidjan, Cote d’Ivoire, April 2014: FONDS CAURIS CROISSANCE II LIMITED, advised by the West African fund manager Cauris Management, agreed to invest in CIPHARM to diversify its range of injectable pharmaceuticals products.   CIPHARM is a Cote d’Ivoire-based leading pharmaceutical company with revenues derived from 12 countries across west and central Africa. The company has been in operations for over 25 years and manufactures a broad range of generic pharmaceuticals (dry forms, syrups and powder) under its own brand names as well as licensed names. Fonds Cauris Croissance II Limited’s investment will allow the company to diversify its range of products with injectable pharmaceuticals, for which there is an increasing demand combined with a severe lack of local production. Commenting on this investment, Mr Ibrahima Diawara, CEO of CIPHARM said: “Fonds Cauris Croissance II investment will take the business to the next level through: 1. the launch of new products including hemodialysis solutions 2. new technical partnerships 3. the strengthening of governance and an improvement in the relationship with banks.”   Source: AVCA

Rédactionhttps://financialafrik.com
Financial Afrik se propose de délivrer l’information financière stratégique aux cadres et dirigeants, à travers une newsletter quotidienne et un site web qui couvre toute la finance africaine.

LAISSER UN COMMENTAIRE

Please enter your comment!
Please enter your name here

ArticlesSIMILAIRES
Nous vous les recommandons spécialement

X